153546-07-7

Basic information

• Product Name: methyl (R)-2-(3-nitrophenoxy)propionate
• Synonyms: methyl (R)-2-(3-nitrophenoxy)propionate
• CAS NO: 153546-07-7
• Molecular Weight: 225.201
• Mol File: 153546-07-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: methyl (R)-2-(3-nitrophenoxy)propionate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (R)-2-(3-nitrophenoxy)propionate(153546-07-7)
• EPA Substance Registry System: methyl (R)-2-(3-nitrophenoxy)propionate(153546-07-7)

Safety Data

• Hazardous Substances Data: 153546-07-7(Hazardous Substances Data)

Upstream product

• 27871-49-4 (S)-Methyl lactate 
• 554-84-7 meta-nitrophenol 
• 17392-83-5 (R)-Methyl lactate 
• 20047-41-0 methyl (2S)-2-bromopropanoate 
• 3118-78-3 potassium-3-nitrophenolate 

Downstream Products

• 1595156-81-2 (R)-2-(3-((R)-2-(3-((R)-2-(3-aminophenoxy)propanamido)phenoxy)propanamido)phenoxy)propanoic acid 
• 1595156-77-6 (R)-methyl 2-(3-((R)-2-(3-((R)-2-(3-aminophenoxy)propanamido)phenoxy)propanamido)phenoxy)propanoate 
• 1595156-75-4 (R)-methyl 2-(3-((R)-2-(3-((R)-2-(3-nitrophenoxy)propanamido)phenoxy)propanamido)phenoxy)propanoate 
• 1595156-73-2 (R)-methyl 2-(3-((R)-2-(3-aminophenoxy)propanamido)phenoxy)propanoate 
• 1595156-70-9 (R)-methyl 2-(3-((R)-2-(3-nitrophenoxy)propanamido)phenoxy)propanoate 
• 867219-48-5 methyl (R)-2-(3-aminophenoxy)propanoate 
• 77285-94-0 (R)-2-(3-nitrophenoxy)propanoic acid 

Relevant articles and documents

Asymmetric synthesis of photophore-containing lactisole derivatives to elucidate sweet taste receptors

Lactisole, which has a 2-phenoxy propionic acid skeleton, is well-known as an inhibitor of sweet taste receptors. We recently revealed some of the structure-activity relationships of the aromatic ring and chiral center of lactisole. Photoaffinity labeling

PIPERIDINE DERIVATES FOR THE TREATMENT OF CHEMOKINES MEDIARED DISEASE

The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.